Roisin Connolly
University College Cork · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Roisin Connolly as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:32 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07893730 · Mapping the Enhanced Landscape of Advanced Breast Cancer fOr DYnamic Treatment ApproachesUniversity College Cork · not yet recruiting · Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer (LABC) · principal investigator
- Ph2NCT01937117 · Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · active not recruiting · Breast Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 12:33 UTC. The ranking covers the 200 most relevant of 21 PubMed records, and a shared surname and initials can bring in a namesake. All 21 on PubMed
- TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.J Clin Oncol · 2019306 citationsRCR 11.1
- Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial.Nat Med · 2024219 citationsRCR 25.8
- 137 citationsRCR 4.3
- Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study.Clin Cancer Res · 2017132 citationsRCR 4.1
- 121 citationsRCR 7.8
- 111 citationsRCR 5.9
- Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial.Nat Cancer · 202454 citationsRCR 6.2
- 52 citationsRCR 1.5
- The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial.Clin Cancer Res · 202044 citationsRCR 2.2
- Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.J Clin Oncol · 202142 citationsRCR 2.2